Geron Corp stories:
Geron, GE Unit To Team Up In Stem-Cell Drug Development Effort
Jun 30th, 2009 - CNNMoney
Geron Corp. (GERN) and General Electric Co.'s (GE) GE Healthcare announced aglobal licensing deal in which the companies will team up to develop and selldrug-discovery technologies derived from human embryonic stem cells.
Geron Corp videos from YouTube:
5:17The Business of Stem Cells (Part 1) - Bloomberg
Spotlight on Geron Corp. - Interview with CEO Thomas Okarma (Bloomberg News) ... NASDAQ:GERN Science Technology Law Legal Issues Health Business Economy Bio-tech Government Politics Religion Spirituality Morality/Ethics Editors Pick
2:34Geron founder Dr. Michael West Talks Stem Cells on CNBC
January 2009: FDA milestone in stem cell research Geron announced that it has received FDA approval to proceed with the first-ever human embryonic stem cell studies. As an accomplished scientist and businessman ...
6:27Stock Trading & Inesting Technical Analysis Review 6/1/07
(AMEX:SMH), iShares Russell 2000 Index (ETF) (Public, NYSE:IWM), Alexion Pharmaceuticals, Inc. (Public, NASDAQ:ALXN), Tetra Tech, Inc. (Public, NASDAQ:TTEK), Presstek, Inc. (Public, NASDAQ:PRST) Cepheid (Public ...
2:35Human Trials of Embryonic Stem Cell Treatment Beginning
cells. The scientists will test a therapy that is designed to regenerate nerve cells in people who have suffered spinal cord injuries. The trial, however, has a limited goal of assessing the safety of the treatment ...
